Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TARA

Protara Therapeutics (TARA)

Protara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TARA
DateTimeSourceHeadlineSymbolCompany
11/03/20228:00AMGlobeNewswire Inc.Protara Therapeutics Announces Third Quarter 2022 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
09/15/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
09/06/20228:00AMGlobeNewswire Inc.Protara Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:TARAProtara Therapeutics Inc
08/15/20225:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
08/10/20226:35AMTipRanksH.C. Wainwright Keeps Their Buy Rating on Protara Therapeutics (TARA)NASDAQ:TARAProtara Therapeutics Inc
08/09/20224:34PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TARAProtara Therapeutics Inc
08/09/20228:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
08/09/20228:00AMGlobeNewswire Inc.Protara Therapeutics Announces Second Quarter 2022 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
07/19/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/19/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/19/20224:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TARAProtara Therapeutics Inc
07/18/20224:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
07/05/20225:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
07/05/20225:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/21/20228:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
06/21/20228:00AMGlobeNewswire Inc.Protara Therapeutics Announces Departure of Chief Financial OfficerNASDAQ:TARAProtara Therapeutics Inc
06/09/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/09/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/09/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/09/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/09/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/09/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/09/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/09/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/09/20224:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
05/26/20225:11PMGlobeNewswire Inc.Protara Therapeutics Announces Trials in Progress Poster Presentation for the ADVANCED-1 Trial in NMIBC at the 2022 American Society of Clinical Oncology Annual MeetingNASDAQ:TARAProtara Therapeutics Inc
05/17/20228:00AMGlobeNewswire Inc.Protara Therapeutics to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:TARAProtara Therapeutics Inc
05/12/20228:00AMGlobeNewswire Inc.Protara Therapeutics Presents Results from Retrospective Analysis of Randomized and Open-Label Studies Evaluating the Safety and Efficacy of OK-432 in Patients with Lymphatic MalformationsNASDAQ:TARAProtara Therapeutics Inc
05/09/20226:25AMTipRanksAnalysts Are Bullish on Top Healthcare Stocks: Electrocore (ECOR), Cardiff Oncology (CRDF)NASDAQ:TARAProtara Therapeutics Inc
05/05/20228:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TARA

Your Recent History

Delayed Upgrade Clock